Archives of Pediatric Infectious Diseases

Published by: Kowsar

Prevalence of Hepatitis B Surface Antigen Among People Attending Medical Diagnostic Laboratories in Neyshabur, Northeast of Iran, During Years 2011 to 2015

Mohammad Salehi 1 , * and Somaye Najafi 2
Authors Information
1 Blood Borne Infections Research Center, Academic Center for Education, Culture and Research (ACECR), Razavi Khorasan Branch, Mashhad, Iran
2 MSc in Biology, Islamic Azad University, Tonekabon Branch, Tonekabon, Iran
Article information
  • Archives of Pediatric Infectious Diseases: October 2017, 5 (4); e61633
  • Published Online: September 27, 2017
  • Article Type: Brief Report
  • Received: October 20, 2016
  • Revised: January 5, 2017
  • Accepted: February 7, 2017
  • DOI: 10.5812/pedinfect.61633

To Cite: Salehi M, Najafi S. Prevalence of Hepatitis B Surface Antigen Among People Attending Medical Diagnostic Laboratories in Neyshabur, Northeast of Iran, During Years 2011 to 2015, Arch Pediatr Infect Dis. 2017 ; 5(4):e61633. doi: 10.5812/pedinfect.61633.

Copyright © 2017, Archives of Pediatric Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Farzadegan H, Shamszad M, Noori-Arya K. Epidemiology of viral hepatitis among Iranian population--a viral marker study. Ann Acad Med Singapore. 1980; 9(2): 144-8[PubMed]
  • 2. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006; 45(4): 529-38[DOI][PubMed]
  • 3. Andre F. Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine. 2000; 18 Suppl 1-2[PubMed]
  • 4. Gust ID. Epidemiology of hepatitis B infection in the Western Pacific and South East Asia. Gut. 1996; 38 Suppl 2-23[PubMed]
  • 5. Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis. 2007; 16(4): 403-6[PubMed]
  • 6. Joshi N, Yr NK, Kumar A. Age related seroprevalence of antibodies to hepatitis A virus in Hyderabad, India. Trop Gastroenterol. 2000; 21(2): 63-5[PubMed]
  • 7. Iran's health and disease surveillance report (in Persian). 2001;
  • 8. Zali MR. Epidemiology of hepatitis B in the Islamic Republic of Iran. East Mediterr Health J. 1996; 2(2): 290-8
  • 9. Alavian SM, Hajarizadeh B, Ahmadzad-Asl M, Kabir A, Bagheri-Lankarani K. Hepatitis B Virus infection in Iran: A systematic review. Hepat Mon. 2008; 8(4): 281-94
  • 10. Salehi M, Alavian SM, Tabatabaei SV, Izadi S, Sanei Moghaddam E, Amini Kafi-Abad S, et al. Seroepidemiology of HBV infection in South-East of iran; a population based study. Iran Red Crescent Med J. 2012; 14(5): 283-8[PubMed]
  • 11. Alavian SM, Tabatabaei SV, Nourizad S, Mansouri F, Khademi N, Amini Kafi-abad S, et al. Seroepidemiology of hbv infection in kermanshah- west of iran; a population based study. Jundishapur J Microbiol. 2012; 5(4): 564-9[DOI]
  • 12. Alavian SM, Tabatabaei SV, Ghadimi T, Beedrapour F, Kafi-Abad SA, Gharehbaghian A, et al. Seroprevalence of Hepatitis B Virus Infection and Its Risk Factors in the West of Iran: A Population-based Study. Int J Prev Med. 2012; 3(11): 770-5[PubMed]
  • 13. Farhat A, Khademi G, Mazlouman SJ. The prevalence of hepatitis B carrier state in Khorassan province of Iran. Saudi Med J. 2003; 24(5): 549-51[PubMed]
  • 14. Honigmann EBCE. Encyclopaedia of Islam. 2013;
  • 15. Lee BS, Cho YK, Jeong SH, Lee JH, Lee D, Park NH, et al. Nationwide seroepidemiology of hepatitis B virus infection in South Korea in 2009 emphasizes the coexistence of HBsAg and anti-HBs. J Med Virol. 2013; 85(8): 1327-33[DOI][PubMed]
  • 16. Todd CS, Abed AM, Strathdee SA, Scott PT, Botros BA, Safi N, et al. HIV, hepatitis C, and hepatitis B infections and associated risk behavior in injection drug users, Kabul, Afghanistan. Emerg Infect Dis. 2007; 13(9): 1327-31[DOI][PubMed]
  • 17. Amini S, Mahmoodi MF, Andalibi S, Solati AA. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study. J Trop Med Hyg. 1993; 96(5): 277-87[PubMed]
  • 18. Alizadeh AH, Ranjbar M, Ansari S, MirArab A, Alavian SM, Mohammad K, et al. Seroprevalence of hepatitis B in Nahavand, Islamic Republic of Iran. East Mediterr Health J. 2006; 12(5): 528-37[PubMed]
  • 19. Nazila K, Behrooz A, AbbasAli J, Ziba F, Peyman A. Hepatitis B Markers in Isfahan, central Iran: A population-based study. Hepat Mon. 2009; 9(1): 12-6
  • 20. Shakeri MT, Foghanian B, Nomani H, Ghayour-Mobarhan M, Nabavinia MS, Rostami S, et al. The prevalence of hepatitis B virus infection in mashhad, iran: a population-based study. Iran Red Crescent Med J. 2013; 15(3): 245-8[DOI][PubMed]
  • 21. World Health Organization. . Introduction of hepatitis B vaccine into childhood immunization services: Management guidelines, including information for health workers and parents. 2001;
  • 22. Moosazadeh M, Amiresmaili MR, Nezammahalleh A. The epidemiology of HBsAg positive cases reported to the health deputy of Mazandaran University of Medical Sciences, Iran. J Health Dev. 2012; 1(2): 130-7
  • 23. Eskandar H, SayedJalal H, AbuulRahim M. Seroepidemiology of hepatitis B virus infection in Khuzestan province, southwest of Iran. Hepat Mon. 2009; 9(1): 34-8
  • 24. Mohebbi SR, Sanati A, Cheraghipour K, Rostami Nejad M, Shalmani HM, Zali MR. Hepatitis C and hepatitis B virus infection: epidemiology and risk factors in a large cohort of pregnant women in Lorestan, West of Iran. Hepat Mon. 2011; 11(9): 736-9[DOI][PubMed]
  • 25. Merat S, Rezvan H, Nouraie M, Jamali A, Assari S, Abolghasemi H, et al. The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study. Arch Iran Med. 2009; 12(3): 225-31[PubMed]
  • 26. Ziaee M, Azarkar G. Prevalence of hepatitis d virus infection among patients with chronic hepatitis B attending birjand hepatitis clinic (East of iran) in 2012. Hepat Mon. 2013; 13(8)[DOI][PubMed]
  • 27. Saffar H, Ajami A, Saffar MJ, Shojaei J, Sotudeh-Anvari M, Shams-Esfandabad K, et al. Prevalence of hepatitis B virus seromarkers in young adults vaccinated at birth; impact on the epidemiology of hepatitis B infection in iran. Hepat Mon. 2014; 14(5)[DOI][PubMed]
  • 28. Darmawan E, El-Khobar KE, Nursanty NK, Thedja MD, Muljono DH. Seroepidemiology and occult hepatitis B virus infection in young adults in Banjarmasin, Indonesia. J Med Virol. 2015; 87(2): 199-207[DOI][PubMed]
  • 29. Zhou Q, Huang F, Chen L, Chen E, Bai L, Cheng X, et al. RPB5-Mediating Protein Suppresses Hepatitis B Virus (HBV) Transcription and Replication by Counteracting the Transcriptional Activation of Hepatitis B virus X Protein in HBV Replication Mouse Model. Jundishapur J Microbiol. 2015; 8(9)[DOI][PubMed]
  • 30. Ang LW, Cutter J, James L, Goh KT. Seroepidemiology of hepatitis B virus infection among adults in Singapore: a 12-year review. Vaccine. 2013; 32(1): 103-10[DOI][PubMed]
  • 31. Mahabadi M, Norouzi M, Alavian SM, Samimirad K, Azad TM, Saberfar E, et al. Drug-related mutational patterns in hepatitis B virus (HBV) reverse transcriptase proteins from Iranian treatment-naive chronic HBV patients. Hepat Mon. 2013; 13(1)[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments